Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. Rafidi
Lrig1 Is an Estrogen-Regulated Growth Suppressor and Correlates With Longer Relapse-Free Survival in ER -Positive Breast Cancer
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Related publications
Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer
Oncology Letters
Cancer Research
Oncology
ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells
PLoS ONE
Multidisciplinary
Intratumoral Expression of CCR3 in Breast Cancer Is Associated With Improved Relapse-Free Survival in Luminal-Like Disease
Oncotarget
Oncology
High IKKα Expression Is Associated With Reduced Time to Recurrence and Cancer Specific Survival in Oestrogen Receptor (ER)-positive Breast Cancer
International Journal of Cancer
Cancer Research
Oncology
EZH2-Regulated DAB2IP Is a Medulloblastoma Tumor Suppressor and a Positive Marker for Survival
Clinical Cancer Research
Cancer Research
Oncology
Maximum Growth and Survival of Estrogen Receptor-Alpha Positive Breast Cancer Cells Requires the Sin3A Transcriptional Repressor
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells
Cancers
Cancer Research
Oncology
HLA Epitope Mismatch in T Cell-Replete Haploidentical Hematopoietic Cell Transplantation Is Associated With Worse Relapse Free Survival and Longer Engraftment
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Improved Relapse-Free Survival on Aromatase Inhibitors in Breast Cancer Is Associated With Interaction Between Oestrogen Receptor-Α and Progesterone Receptor-B
British Journal of Cancer
Cancer Research
Oncology
